3D Systems Corporation · NYSE:DDD
3D Systems — Investor Presentation (March 2021)
24 slides from 3D Systems's investor presentation, March 2021
Slide 1: Investor Presentation
Investor Presentation March 2021 ©2021 3D Systems, Inc. | All Rights Reserved.
Slide 2: Safe Harbor
Safe Harbor Certain statements made in this presentation that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals
Slide 3: Key Messages
Key Messages New management team executing A leader in a large growth market Full Solution capabilities with focus a transformation journey on application driven growth 3
Slide 4: New Leader. New Future.
New Leader. New Future. Dr. Jeffrey Graves is President and CEO of 3D Systems and joined the company on May 26, 2020. Prior to joining 3D Systems, from 2012 to May 2020, he served as CEO, President and Director of MTS Systems Corporation, a global supplier of test, simulation, and measurement system
Slide 5: Purpose Statement
Purpose Statement We are the leaders in enabling additive manufacturing solutions for applications in growing markets that demand high reliability products. 5
Slide 6: Transformation Framework
Transformation Framework Strategic Divest/ Reorganize Restructure Purpose Invest We are the leaders in Focus on Key Applications Resizing + other cost Divest non-core assets enabling additive within Healthcare and reduction measures and Invest for growth manufacturing solutions Industrial Markets fo
Slide 7: Why AM? Tangible Benefits to AM Design
Why AM? Tangible Benefits to AM Design Capability for Mass Improved Lead Part / Assembly Customization Times Consolidation Supply Chain Precision Weight Optimization and Parts Reduction Flexibility 7
Slide 8: Market Opportunity: AM Growth Estimate
Market Opportunity: AM Growth Estimate SCALE OF AM GROWTH Over the next 5 years, market is expected to grow on average at 24% CAGR, reaching $35B by 2024 INDUSTRY GROWTH DRIVERS High focus to introduce new designs & business models that take full advantage of the manufacturing freedom Growth is expe
Slide 9: Application Focus
Application Focus Healthcare Solutions Industrial Solutions Dental Applications Aerospace & Defense Medical Applications Transportation & Motorsports Medical Devices Investment Castings Simulations Jewelry Surgical Planning Consumer Durables & Electronics Focus on Key Applications within these Marke
Slide 10: Full Solution Provider
Full Solution Provider Services and Software Hardware and Materials Application experts & Customer Full range of 3D printers to address Innovation Centers AM needs in metals, plastics and wax Printing process and management Professional and production systems software tools 100+ Materials portfolio
Slide 11: Veterans Health Administration (VHA)
Healthcare Case Study Veterans Health VA Objectives • COVID-19 related manufacturing Administration (VHA) • Establish quality management system • Develop patient-matched medical device products • Regulatory compliance 3D Systems Solution 3D Systems will assist the VA with • Hardware / materials esta
Slide 12: Orthopedic
Healthcare Case Study Orthopedic Customer Challenge Machining-plus-coating traditional design and manufacturing Utilized holistic solutions approach processes lead to poor surface quality, high component to develop and commercialize the variability, long process cycle times, high inventory and waste
Slide 13: Investment Casting
Industrial Case Study Investment Casting Customer Challenge Traditional investment casting production methodology Utilized holistic solutions with limits geometric design options and involves long, materials, hardware and software complex manufacturing cycle times. elements tuned by application expe
Slide 14: Investing for Growth
Investing for Growth ORGANIZATIONAL MATERIALS PROGRAMS DEVELOPMENT − Solution selling − Polymer − Regenerative capability − High-temperature, Medicine − People and talent lightweight materials − Roadrunner ‘High − Customer Success for industrial Speed Fusion’ Team created to applications − Product f
Slide 15: Regenerative Medicine
Regenerative Medicine Industry Challenges Through bioprinting, we have an Demonstrate the capability to print complex thin- opportunity to address patient needs walled structured using biocompatible materials for for organs and soft tissue development applications such as tissue-on-a-chip, using Add
Slide 16: "Roadrunner" High Speed Fusion
“Roadrunner” High Speed Fusion Industry Challenges Address demanding aerospace and advanced Specific Applications automotive applications with size, speed and – Direct Printing: aerospace interiors precision that exceeds current market offerings. and ducting, drone components, automotive under dash
Slide 17: Q4 2020 Revenue by Market
Quarter ended 12/31/20 $ in millions Q4 2020 Revenue by Market (Unaudited) 42.4% 14.2% 48.0% (21.6)% 17
Slide 18: Operating Expense Trend
Operating Expense Trend Non-GAAP operating expenses decreased 15.8% in Q4 2020 compared to Q4 2019 as we saw benefits of restructuring efforts 18 See appendix for a reconciliation of Non-GAAP operating expenses.
Slide 19: Adjusted EBITDA
Adjusted EBITDA Defined as non-GAAP Operating Income plus Depreciation Q4 2020 improvement as a result of business growth and restructuring efforts See appendix for a reconciliation of Non-GAAP Operating Profit and Adjusted EBITDA.19
Slide 20: Summary
Summary Our Transformation Journey Continues: • Reorganization and Restructuring complete • Exploring additional divestitures of non-core assets • Investing for growth in core business of additive manufacturing • Focus on operational execution 20
Slide 21: Thank You
Thank You Find out more at: www.3dsystems.com 2 21 1 ©2019 3D Systems, Inc. | All Rights Reserved.
Slide 22: Appendix
Appendix ©2021 3D Systems, Inc. | All Rights Reserved.
Slide 23: Non-GAAP Reconciliation - Operating Income (Loss)
Non-GAAP Reconciliation - Operating Income (Loss) (Unaudited) Fourth Quarter and Full Year Non-GAAP Operating Loss Quarter Ended December 31, Year Ended December 31, (in millions, except per share amounts) 2020 2019 2020 2019 GAAP Operating income (loss) $ 0.7 $ (4.7) $ (119.0) $ (57.1) Adjustments:
Slide 24: Non-GAAP Reconciliation - Operating Expense
Non-GAAP Reconciliation - Operating Expense (Unaudited) Quarterly 2019 and 2020 Non-GAAP Operating Expenses 2019 2019 2020 2020 Quarter Ended Full Quarter Ended Full (in millions) Mar 31 Jun 30 Sep 30 Dec 31 Year Mar 31 Jun 30 Sep 30 Dec 31 Year GAAP SG&A Expenses $ 65.1 $ 71.7 $ 58.3 $ 59.3 $ 254.4